← Browse by Condition
Medical Condition
gastric adenocarcinoma
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 2, Phase 3, Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for gastric adenocarcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — gastric adenocarcinoma Clinical Trials
How many clinical trials are currently recruiting for gastric adenocarcinoma?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for gastric adenocarcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for gastric adenocarcinoma?
gastric adenocarcinoma research spans Phase 1 (1 trial), Phase 2 (5 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a gastric adenocarcinoma clinical trial?
Eligibility criteria for gastric adenocarcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 5
Phase 3 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06028737 Phase 2, Phase 3
Recruiting
Enrollment
150 pts
Location
Lithuania, Ukraine
Sponsor
Ukrainian Society of Clinical ...
NCT07607119
Recruiting
Enrollment
53 pts
Location
South Korea
Sponsor
Samsung Medical Center
NCT06761846 Phase 2
Recruiting
Enrollment
70 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
NCT07486518
Recruiting
Enrollment
4,000 pts
Location
India
Sponsor
Asian Institute of Gastroenter...
NCT06038578 Phase 2
Recruiting
Enrollment
146 pts
Location
United States, Japan...
Sponsor
Toray Industries, Inc
NCT07673887 Phase 3
Recruiting
Enrollment
570 pts
Location
United States, China...
Sponsor
Astellas Pharma Global Develop...
NCT07529808 Phase 1, Phase 2
Recruiting
Enrollment
164 pts
Location
United States
Sponsor
BigHat Biosciences, Inc.
NCT06943781
Recruiting
Enrollment
15,000 pts
Location
China
Sponsor
Fudan University
NCT04850729
Recruiting
Enrollment
169 pts
Location
China
Sponsor
Nanfang Hospital, Southern Med...
NCT06422403 Phase 2
Recruiting
Enrollment
360 pts
Location
Singapore
Sponsor
National University Hospital, ...
Related Conditions
gastric cancer (3) gastroesophageal junction adenocarcinoma (3) gastroesophageal cancer (2) gastroesophageal junction gej adenocarcinoma (2) stomach cancer (1) advanced gastric adenocarcinoma (1) gastric neoplasm (1) stomach neoplasm (1) gastrointestinal cancer (1) advanced gastroesophageal junction adenocarcinoma (1) advanced gastric carcinoma (1) chemotherapy (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology